Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer

Matrix metalloproteinase 9 (MMP9) and microRNA-145 (miR-145) have emerged as essential biomarkers in thyroid cancer progression and metastasis. However, their combined evaluation and clinical utility as a unified prognostic marker across diverse thyroid cancer subgroups remain unexplored. We investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Toraih, Eman A., Hussein, Mohamed H., Al Ageeli, Essam, Ellaban, Mohamad, Kattan, Shahd W., Moroz, Krzysztof, Fawzy, Manal S., Kandil, Emad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669161/
https://www.ncbi.nlm.nih.gov/pubmed/38001954
http://dx.doi.org/10.3390/biomedicines11112953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669161/
https://www.ncbi.nlm.nih.gov/pubmed/38001954
http://dx.doi.org/10.3390/biomedicines11112953

Ejemplares similares